NASDAQ Composite opens in less than fourteen hours and Arena Pharmaceuticals’s premarket value is already 1.67% down.
The last session, NASDAQ Composite finished with Arena Pharmaceuticals rising 1.71% to $78.31. NASDAQ Composite jumped 0.43% to $13,128.95, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session.
Arena Pharmaceuticals’s last close was $76.99, 15.17% under its 52-week high of $90.19.
Arena Pharmaceuticals’s Sales
Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 3.59%, 0.54%, and 0.41%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 5.86%, 4.01%, and 3.51%, respectively.